RENEWAL EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • May 5th, 2017 • Accuray Inc • Surgical & medical instruments & apparatus • California
Contract Type FiledMay 5th, 2017 Company Industry JurisdictionThis Employment Agreement (“Agreement”) is entered into and effective as of January 1, 2017 (“Effective Date”), by and between Accuray Incorporated, a Delaware corporation (the “Company”), and Kelly Londy (“Executive”).
AMENDMENT NO. 2 TO FINANCING AGREEMENTFinancing Agreement • May 5th, 2017 • Accuray Inc • Surgical & medical instruments & apparatus • New York
Contract Type FiledMay 5th, 2017 Company Industry JurisdictionAMENDMENT NO. 2 TO FINANCING AGREEMENT, dated as of March 10, 2017 (this “Amendment”), is an amendment to the Financing Agreement, dated as of January 11, 2016 (as amended, restated, supplemented or otherwise modified from time to time, the “Financing Agreement”), by and among Accuray Incorporated, a Delaware corporation (the “Administrative Borrower”), TomoTherapy Incorporated, a Wisconsin corporation (“TomoTherapy”), and together with the Administrative Borrower, each a “Borrower” and, collectively, the “Borrowers”), each subsidiary of the Administrative Borrower listed as a “Guarantor” on the signature pages thereto (together with each other Person that executes a joinder agreement and becomes a “Guarantor” thereunder, each a “Guarantor” and, collectively, the “Guarantors”), the lenders from time to time party thereto (each a “Lender” and collectively, the “Lenders”), Cerberus Business Finance, LLC, a Delaware limited liability company (“Cerberus”), as collateral agent for the Lende
RENEWAL EXECUTIVE EMPLOYMENT AGREEMENTRenewal Executive Employment Agreement • May 5th, 2017 • Accuray Inc • Surgical & medical instruments & apparatus • California
Contract Type FiledMay 5th, 2017 Company Industry JurisdictionThis Employment Agreement (“Agreement”) is entered into and effective as of January 1, 2017 (“Effective Date”), by and between Accuray Incorporated, a Delaware corporation (the “Company”), and Alaleh Nouri (“Executive”).